Find your path to Dmitri
474 people in our graph share verified history with Dmitri — schools, employers, funds. One of them is your warm intro.
Adam ValkinunlockedDmitri: together at Harvard University (1996)
×10Dmitri: together at Harvard University
Dmitri: together at Jounce Therapeutics, Inc.
About
Dmitri Wiederschain is Chief Scientific Officer at Crossbow Therapeutics, Inc. His work focuses on oncology drug development, including tumor immunobiology and cancer cell-intrinsic mechanisms, with expertise in immuno-oncology, cancer biology, and the pre-clinical development of multi-specific biologics, RNA therapeutics, and small molecules. He has experience leading multi-disciplinary teams through pre-clinical drug development and advancing multiple drug candidates.
Executive at Crossbow Therapeutics
Intro paths
→
In turn, Dmitri can intro founders to Crossbow Therapeutics's investors below.
Crossbow Therapeutics's investors · 7
Biotechnology Value FundSan Francisco · since 2023Mirae Asset Venture Investment$594K – $54M checks · since 2023MPM BioImpactBoston · $1M – $15M checks · since 2025Pfizer Venture Investments$5M – $20M checksPfizer Venturessince 2026Polaris PartnersBoston · $500K – $5M checks · since 2025Taiho Ventures, LLCMenlo Park · since 2026
Experience
- Stealth Mode BiotechChief Executive Officercurrent2026 — presentGreater Boston
- Crossbow Therapeutics, IncChief Scientific Officercurrent2023 — presentCambridge, Massachusetts, United States
- Self-employedCancer Drug Discovery2023
- Jounce Therapeutics, Inc.Chief Scientific Officer2021 — 2023Cambridge, Massachusetts, United States
- SanofiGlobal Head of Immuno-Oncology Research Therapeutic Area2018 — 2021Cambridge, MA
- SanofiHead of Active Immunization Cluster, Immuno-Oncology Research Therapeutic Area2017 — 2018Cambridge, MA
- SanofiSection Head, Oncology Discovery2013 — 2017Cambridge, MA
- SanofiPrincipal Research Investigator/ Laboratory Head, Oncology Discovery2010 — 2013Cambridge, MA
- Novartis Institutes for BioMedical ResearchInvestigator II/ Laboratory Head2007 — 2010Cambridge, MA
- Novartis Institutes for BioMedical ResearchPresidential Fellow2004 — 2007
Skills & more
Drug Discovery35Oncology18Clinical Development15Cancer8In Vivo9Drug Development9Cancer Research5Life Sciences7In Vitro3Pharmacology3PK/PD2Metabolism1
+3 more
Molecular & Cellular BiologyRNA therapeuticsImmuno-oncologyLanguages English · Russian
From Dmitri's professional profile.
Frequently asked questions
- Who is Dmitri Wiederschain?
- Dmitri Wiederschain is Chief Scientific Officer at Crossbow Therapeutics, Inc. His work focuses on oncology drug development, including tumor immunobiology and cancer cell-intrinsic mechanisms, with expertise in immuno-oncology, cancer biology, and the pre-clinical development of multi-specific biologics, RNA therapeutics, and small molecules. He has experience leading multi-disciplinary teams through pre-clinical drug development and advancing multiple drug candidates.
- Where does Dmitri Wiederschain work?
- Dmitri Wiederschain is Executive at Crossbow Therapeutics.
- Where did Dmitri Wiederschain go to school?
- Dmitri Wiederschain studied at Harvard University (Ph.D., Cancer Biology); Harvard University (ALB, Natural Sciences); Sechenov University (Medicine).
Same school
Also attended Harvard University2,000
Ron ConwayFounder of SV AngelAlfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalG
+ 1,994 more
Also attended Sechenov University1
Shared employers
Also worked at Stealth Mode Biotech14
Rebecca MancusiInvestor at Third Rock VenturesJack LevyInvestor at Israel Cleantech VenturesVincent RulandEntrepreneur-in-Residence at Versant VenturesSanket AgrawalExecutives in Residence at GENERAL INCEPTIONHugo HiltonPrincipal at Third Rock VenturesKevin CyrResearch Associate at Global BioAccess Fund
+ 8 more
Also worked at Crossbow Therapeutics, Inc4
Also worked at Jounce Therapeutics, Inc.7
Jigar RaythathaInvestor at Third Rock VenturesJason FullerPartner at Deerfield Management CompanyMonica GostissaChief Science Officer at Matrisome BioTatiana NovobrantsevaChief Scientific Officer at NextPoint TherapeuticsKomal JoshiExecutive Officer at Imbria PharmaceuticalsIgor FeldmanFounder at Verseau Therapeutics
+ 1 more
Also worked at Sanofi248
Steve LiapisManaging Director at Northpond VenturesWalter OlesiakOperating Partner at Remiges Ventures, Inc.Christine AylwardFounder & Managing Partner at Magnetic VenturesAlan WaltsVenture Partner at Advent Life SciencesSun AltbachSenior Scientific Advisor at BOLD LongevityMatt VineSenior Associate at RRE Ventures
)
+ 242 more